treatment is influenced by
- pre-existing vascular disease
- other risk factors
- associated conditions (diabetes and renal disease) & target organ damage
- improve long term survival and quality of life
- reduce blood pressure
- reduce overall cardiovascular risk
- minimise end-organ damage
"Remember to remove, revise, or substitude drugs which may be causing hypertension (eg NSAIDs, corticosteroids, oral contraceptives)" Murtagh's General Practice 5th edition.
Individual and population interventions to reduce blood pressure, stroke and vascular disease (From Medicine Today sept 2009 vol 10 number 9 p 62; and Guidelines for the management of absolute cardiovascular disease risk p 39)
- decrease weight (ideal weight is BMI <25 and waist circ < 94 cm in men (<90 Asian men) and < 80cm in women (including Asian women).
- physical exercise (minimum 30 mins 5 to 7 times a week)
- reduce salt < 6 grams a day (= 2300 mg sodium)
- reduce alcohol (<2 drinks a day and 2 alcohol free days)
- increase unsaturated fat intake
- increase fresh fruit and vegetable intake
- use drug therapy in high risk individuals
- no smoking
Immediate treatment to lower blood pressure is recommended in the following situations:
- Systolic blood pressure 180 mmHg or greater (grade 3 hypertension) and or
- Diastolic blood pressure 110 mmHg or greater
- Systolic blood pressure 160 mmHg or greater and diastolic blood pressure 70 mmHg or less (isolated systolic hypertension with widened pulse pressure)
- Patients with associated conditions (for example, stroke or myocardial infarction) or evidence of end-organ damage (for example, microalbuminuria, left ventricular hypertrophy) also need urgent treatment (see the tables below)
- Patients assessed as being at "high risk" following 5 year absolute risk assessment
Associated clinical conditions
|
|
Diabetes
|
Ø
> age 60
Ø
With urine ACR >2.5 male or > 3.5 female
|
Cerebrovascular
disease
|
Ø
Ischaemic or haemorrhagic stroke
Ø
TIA
|
Coronary
heart disease
|
Ø
MI
Ø
Angina
Ø
Stent/ angioplasty
|
Chronic
heart failure
|
|
Chronic
kidney disease
|
Ø
Diabetic nephropathy
Ø
GN
Ø
Hypertensive kidney disease
|
Aortic
disease
|
Aneurism
(dissecting or fusiform)
|
Peripheral
Arterial Disease
|
Clinically
or ABI < 0.9
|
Hypercholesterolaemia
|
>7.5
total
|
Family
history of:
|
Premature
cardiovascular disease
|
Previous
diagnosis of:
|
Familial
hypercholesterolaemia
|
End Organ Disease
|
|
LVH
|
Diagnosed
on ECG or echo (see previous blog)
|
Microalbuminuria
|
|
Chronic
kidney disease
|
Presence
of either
Ø
Proteinuria
Ø
eGFR < 60
|
Vascular
disease
|
Ø
Atherosclerosis evident on ultrasound or radiology
Ø
Hypertensive retinopathy grade II or higher
|
From Heart Foundation Guide to Management 2010 guide
The most up to date guidelines on blood pressure that I can find are the "National Vascular Disease Prevention Alliance Guidelines for the management of absolute cardiovascular disease risk". 2012.
In contrast to the 2008 (updated 2010) guidelines from the Heart Foundation "Guide to the Management of Hypertension", the former, more recent guidelines, recommend immediately treating anyone who is over age 45, at low or moderate risk (based on the Australian cardiovascular risk charts) with blood pressure ≥ 160/100.
Treatment should begin with any of the following
- ACEi or ARB
- CCB (dihydropyridine)
- Low dose thiazide or thiazide like diuretic (in patients > age 65)*
* Note that thiazide diuretics have been associated with increased risk of new onset diabetes therefore use cautiously in patients with "pre-diabetes" or metabolic syndrome. The Heart foundation recommends reserving these agents as first-line for older patients in whom the benefits of managing isolated systolic hypertension and preventing stroke are likely to outweigh the risk of diabetes onset.
Always begin with the LOWEST recommended dose (e.g. ACEi or ARB).
If target not reached after 6 week trial
suggest ACEi (or ARB) + CCB (dihydropyridine)
If target not reached at 3 months
suggest ACEi (or ARB) + CCB + Thiazide
Beta Blockers are recommended post MI and in the setting of angina. Exercise caution in patients with depression, uncontrolled heart failure, bradycardia/ AV block and asthma/ COPD.
Combinations to avoid:
X ACEi
(or ARB) + potassium sparing diuretic (spironolactone, amiloride)
= hyperkalaemia
X Beta
blocker + verapamil
= heart block
X ACEi
+ ARB
= hypotension and lack of efficacy
Common Adverse Effects
ACEi (and ? ARB) can cause cough
CCBs may cause constipation (especially verapamil), flushing, headache and oedema
Thiazide diuretics can cause gout
Beta blockers can cause depression, lethargy, erectile dysfunction
CCBs may cause constipation (especially verapamil), flushing, headache and oedema
Thiazide diuretics can cause gout
Beta blockers can cause depression, lethargy, erectile dysfunction
If blood pressure is not responding to medication, reassess for;
- non adherence
- undiagnosed secondary cause
- hypertensive effects of other drugs
- treatment resistance due to sleep apnoea
- hidden use of alcohol or recreational drugs
- unrecognised high salt intake
- white coat hypertension
- technical factors affecting measurement
- volume overload in CCF
- Lisinopril 20mg daily and Olmesartan 30mg once daily
- Eplerenone 50mg and Captopril 25mg
- Atenolol 50mg daily and Verapamil CR 240mg once daily
- Carvedilol 50mg and Amlodipine 10mg in a patient with CHD
Following blogs will cover management of hypertension in particular situations such as pregnancy, diabetes, stroke etc